Research warning about chemotherapy residues

Waste residues from powerful anti-cancer drugs used in chemotherapy could cause genetic changes even though levels in the environment are considered to be safe, say EU researchers. Environmental monitoring is the first step towards reducing the potential risk.
Date: 
28/06/2016 - 17:26
Project coordinator: 
CYTOTHREAT

The risk posed by pharmaceutical residues in the environment has been recognised for more than 30 years. Concerns have centred on traces of antibiotics, which can induce resistance in harmful bacteria, and endocrine disruptors, which can alter the action of hormones in the human body. Very little work has however been done on the powerful chemotherapy drugs used in the treatment of cancer. These ‘cytostatic’ drugs are designed to attack the DNA of cancer cells; so what happens if they find their way into the aquatic environment?

Read more

Project: 
Fate and effects of cytostatic pharmaceuticals in the environment and the identification of biomarkers for and improved risk assessment on environmental exposure
Rapid Press Release: 
Do Not Publish as Rapid Press Release
Contact
Source: 
http://ec.europa.eu/programmes/horizon2020/en/news/research-warning-about-chemotherapy-residues

Share this post